We are live on ! Find out more
CPC

Cookson Peirce & Co Portfolio holdings

AUM $3.04B
1-Year Est. Return 94.11%
This Fund
S&P 500
This Quarter Est. Return
+10.82%
1 Year Est. Return
+94.11%
3 Year Est. Return
+306.52%
5 Year Est. Return
+526.41%
10 Year Est. Return
+3,285.24%
AUM
$1.54B
AUM Growth
+$120M
Cap. Flow
-$6.56M
Cap. Flow %
-0.43%
Top 10 Hldgs %
29.96%
Holding
232
New
47
Increased
111
Reduced
37
Closed
30

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$31.9M
2
LW icon
Lamb Weston
LW
+$24.1M
3
VRTX icon
Vertex Pharmaceuticals
VRTX
+$18.1M
4
GS icon
Goldman Sachs
GS
+$17.5M
5
FCNCA icon
First Citizens BancShares
FCNCA
+$16.3M

Top Sells

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$31.8M
2
SNPS icon
Synopsys
SNPS
+$26.6M
3
KIM icon
Kimco Realty
KIM
+$23.1M
4
NI icon
NiSource
NI
+$21.1M
5
UNP icon
Union Pacific
UNP
+$17.8M

Sector Composition

Rank Sector Weight
1 Healthcare 18.76%
2 Technology 16.54%
3 Financials 14.35%
4 Industrials 13.12%
5 Consumer Staples 10.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CMG icon
151
Chipotle Mexican Grill
CMG
$47.2B
$413K 0.03%
+14,900
New +$445K
IHF icon
152
iShares US Healthcare Providers ETF
IHF
$1.21B
$406K 0.03%
7,575
+30
+0.4% +$1.61K
VGT icon
153
Vanguard Information Technology ETF
VGT
$139B
$384K 0.03%
9,608
-3,360
-26% -$137K
HPQ icon
154
HP
HPQ
$24.9B
$382K 0.02%
+14,205
New +$393K
G icon
155
Genpact
G
$5.96B
$380K 0.02%
+8,212
New +$373K
EWC icon
156
iShares MSCI Canada ETF
EWC
$6.13B
$374K 0.02%
11,438
+24
+0.2% +$795
SBUX icon
157
Starbucks
SBUX
$120B
$361K 0.02%
+3,635
New +$343K
BNY
158
Bank of New York Mellon
BNY
$106B
$360K 0.02%
+7,898
New +$339K
AVY icon
159
Avery Dennison
AVY
$13B
$353K 0.02%
+1,952
New +$348K
SNV
160
DELISTED
Synovus
SNV
$350K 0.02%
+9,317
New +$370K
AJG icon
161
Arthur J. Gallagher & Co
AJG
$64.1B
$336K 0.02%
1,783
WCC
162
WESCO International
WCC
$16.7B
$312K 0.02%
2,492
+639
+34% +$80.5K
CDW icon
163
CDW
CDW
$18.9B
$304K 0.02%
1,702
+260
+18% +$45.7K
EWBC icon
164
East-West Bancorp
EWBC
$17.9B
$292K 0.02%
4,424
+1,199
+37% +$82.1K
DDD icon
165
3D Systems Corp
DDD
$431M
$290K 0.02%
39,198
BSCN
166
DELISTED
Invesco BulletShares 2023 Corporate Bond ETF
BSCN
$274K 0.02%
13,046
-392,686
-97% -$8.21M
FCN icon
167
FTI Consulting
FCN
$4.4B
$273K 0.02%
1,720
+250
+17% +$41.7K
IHE icon
168
iShares US Pharmaceuticals ETF
IHE
$1.46B
$272K 0.02%
4,383
AZN icon
169
AstraZeneca
AZN
$263B
$268K 0.02%
1,976
-253,780
-99% -$31.8M
BX icon
170
Blackstone
BX
$102B
$266K 0.02%
3,592
-345
-9% -$29.8K
MPLX icon
171
MPLX
MPLX
$59.3B
$263K 0.02%
8,000
IXJ icon
172
iShares Global Healthcare ETF
IXJ
$4.07B
$257K 0.02%
3,023
+10
+0.3% +$825
CFR icon
173
Cullen/Frost Bankers
CFR
$10.4B
$255K 0.02%
1,908
+272
+17% +$38.7K
NVT icon
174
nVent Electric
NVT
$24.9B
$255K 0.02%
+6,632
New +$245K
IBB icon
175
iShares Biotechnology ETF
IBB
$9.34B
$247K 0.02%
1,882

Similar funds

Cookson Peirce & Co's Q4 2022 Portfolio in Review

As of Q4 2022, Cookson Peirce & Co held 232 positions worth $1.54B, up 8.4% from $1.42B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Cookson Peirce & Co's Q4 2022 filing shows 47 new, 111 increased, 37 reduced and 30 closed positions. Its largest new stake was Lamb Weston: 283,180 shares worth $25.3M. The largest sale was AstraZeneca, an estimated $31.8M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 16% a quarter earlier, followed by Technology and Financials.

  • Cookson Peirce & Co's largest Q4 2022 buy was Lamb Weston: 283,180 shares worth $25.3M.
  • Cookson Peirce & Co added most to Merck in Q4 2022, an estimated $31.9M increase.
  • Cookson Peirce & Co's biggest Q4 2022 reduction was AstraZeneca, cutting an estimated $31.8M.
  • Cookson Peirce & Co fully exited Synopsys in Q4 2022, selling an estimated $26.6M.
  • Cookson Peirce & Co's ten largest holdings make up 30% of its $1.54B portfolio in Q4 2022.
  • Cookson Peirce & Co opened 47 new positions and closed 30 in Q4 2022.
  • Cookson Peirce & Co's portfolio value rose 8.4% quarter-over-quarter to $1.54B.

Based on Cookson Peirce & Co's 13F filing for Q4 2022, filed 31 Jan 2023.